(50,000 IU of cholecalciferol) supplementation had a positive impact in RA patients compared to conventional DMARDs drugs, as was clear from the significant FACIT-F.
Keyphrases
- rheumatoid arthritis patients
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- end stage renal disease
- juvenile idiopathic arthritis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- patient reported outcomes
- sleep quality
- systemic sclerosis
- interstitial lung disease